Wolters Kluwer Pharma Solutions, Inc., a US-based provider of scientific information and analytics to professionals in the pharmaceutical and biotech fields, has announced that the Adis journal Drugs in R&D has been transformed from fee-based access to open access (OA). The journal is Adis's first publication to embrace OA. All of the journal's content published will now be available online free of charge.
First launched in 1999 on a subscription and pay-per-view basis, Drugs in R&D includes original research and reviews from all phases of clinical development. The journal is Medline indexed and available on both Ovid and AdisOnline, providing high global visibility.
Drugs in R&D offers an optional Rapid Publishing Service which allows publication of new research in four weeks from submission. Before any submitted article is published, it must be accepted by a panel of independent peer reviewers. The company then charges a nominal fee to cover the cost of publication.
Search for more pharma related books/journals
